A Multi-centre, Double-blind, Parallel-group, Randomised Controlled Study to Investigate Efficacy and Safety of Orally Administered BI 425809 During a 12-week Treatment Period Compared to Placebo in Patients With Cognitive Impairment Due to Alzheimer's Disease.
收藏DataCite Commons2025-05-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00009465/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The study is designed to compare the effects of BI 425809 compared to placebo in patients
with cognitive impairment due to Alzheimer's Disease.
提供机构：
Vivli
创建时间：
2023-11-29
